HANSA BIOPHARMA
Live / Registered — Registered (as of 07 Jan 2020)
What this means for you
Registered since 07 Jan 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88196717
- Registration number
- 5952995
- Mark type
- Stylized text
- Filed
- 16 Nov 2018
- Published for opposition
- 22 Oct 2019
- Registered
- 07 Jan 2020
- Attorney of record
- Gregory J. Chinlund
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, pharmaceutical preparations for use in organ transplantation and treatment of acute autoimmune diseases; pharmaceutical and veterinary preparations, namely, enzyme preparations and sterilizing preparations; sanitary preparations, namely, chemical enzyme preparations and sterilizing preparations; medicines for diagnosing, preventing, and treating cancer and autoimmune diseases for human and veterinary purposes; pharmaceutical preparations for elimination of antibodies for therapeutic purposes in immune related diseases and conditions; enzymes for medical purposes
- Class 042 — Scientific and technological services: Scientific and technological services, namely, pharmaceutical product development and research and design relating thereto; industrial analysis and research in the field of pharmaceutical products
Owner
- HANSA BIOPHARMA AB, LUND, SE
- HANSA BIOPHARMA AB, LUND, SE
- Hansa Medical AB, Lund, SE
- Hansa Medical AB, Lund, SE
Prosecution history
- 07 Jan 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 07 Jan 2020 — REGISTERED-PRINCIPAL REGISTER
- 17 Dec 2019 — ASSIGNMENT OF OWNERSHIP UPDATED MANUALLY
- 22 Oct 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 22 Oct 2019 — PUBLISHED FOR OPPOSITION
- 02 Oct 2019 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 02 Oct 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 15 Sept 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 29 Aug 2019 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 29 Aug 2019 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 28 Aug 2019 — ASSIGNED TO LIE
- 20 Aug 2019 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 27 Feb 2019 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 27 Feb 2019 — NON-FINAL ACTION E-MAILED
- 27 Feb 2019 — NON-FINAL ACTION WRITTEN